Maarten Ooms is a scientific project leader at the Belgian nuclear research center (SCK CEN) with expertise in many aspects of radiopharmaceutical development. Within SCK CEN, Maarten and his team focus on the development of innovative radiopharmaceuticals for Targeted Radionuclide Therapy. Additionally, his research group focusses on development of new radionuclides that can be used for the next generation of therapeutic radiopharmaceuticals.